Gout

被引:1182
作者
Richette, Pascal [1 ]
Bardin, Thomas [1 ]
机构
[1] Univ Paris 07, Hop Lariboisiere, APHP, UFR Med, F-75475 Paris 10, France
关键词
SERUM URIC-ACID; 3RD NATIONAL-HEALTH; EVIDENCE BASED RECOMMENDATIONS; LIVER-TRANSPLANT PATIENTS; TOPHACEOUS GOUT; RISK-FACTORS; SYNOVIAL-FLUID; MYCOPHENOLATE-MOFETIL; INFLAMMATORY PROCESS; METABOLIC SYNDROME;
D O I
10.1016/S0140-6736(09)60883-7
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Gout is a common arthritis caused by deposition of monosodium. urate crystals within joints after chronic hyperuricaemia. It affects 1-2% of adults in developed countries, where it is the most common inflammatory arthritis in men. Epidemiological data are consistent with a rise in prevalence of gout. Diet and genetic polymorphisms of renal transporters of urate seem to be the main causal factors of primary gout. Gout and hyperuricaemia are associated with hypertension, diabetes mellitus, metabolic syndrome, and renal and cardiovascular diseases. Non-steroidal anti-inflammatory drugs and colchicine remain the most widely recommended drugs to treat acute attacks. Oral corticosteroids could be an alternative to these drugs. Interleukin 1 beta is a pivotal mediator of acute gout and could become a therapeutic target. When serum uric acid concentrations are lowered below monosodium urate saturation point, the crystals dissolve and gout can be cured. Patient education, appropriate lifestyle advice, and treatment of comorbidities are an important part of management of patients with gout.
引用
收藏
页码:318 / 328
页数:11
相关论文
共 150 条
[1]
New-onset gout after kidney transplantation: Incidence, risk factors and implications [J].
Abbott, KC ;
Kimmel, PL ;
Dharnidharka, V ;
Oglesby, RJ ;
Agodoa, LY ;
Caillard, S .
TRANSPLANTATION, 2005, 80 (10) :1383-1391
[2]
Validation of the health assessment questionnaire disability index in patients with gout [J].
Alvarez-Hernandez, Everardo ;
Pelaez-Ballestas, Ingris ;
Vazquez-Mellado, Janitzia ;
Teran-Estrada, Leobardo ;
Guishlaine Bernard-Medina, Ana ;
Espinoza, Jesus ;
Aceves-Avila, Francisco J. ;
Goycochea-Robles, Maria V. ;
Garza, Mario ;
Ventura, Lucio ;
Burgos-Vargas, Ruben .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (05) :665-669
[3]
Alvarez-Nemegyei J, 2005, J RHEUMATOL, V32, P2189
[4]
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005 [J].
Annemans, L. ;
Spaepen, E. ;
Gaskin, M. ;
Bonnemaire, M. ;
Malier, V. ;
Gilbert, T. ;
Nuki, G. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) :960-966
[5]
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans [J].
Anzai, Naohiko ;
Ichida, Kimiyoshi ;
Jutabha, Promsuk ;
Kimura, Toru ;
Babu, Ellappan ;
Jin, Chun Ji ;
Srivastava, Sunena ;
Kitamura, Kenichiro ;
Hisatome, Ichiro ;
Endou, Hitoshi ;
Sakurai, Hiroyuki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (40) :26834-26838
[6]
Hyperuricaemia - Where nephrology meets rheumatology [J].
Avram, Z. ;
Krishnan, E. .
RHEUMATOLOGY, 2008, 47 (07) :960-964
[7]
COMPARISON OF PARENTERAL ADRENOCORTICOTROPIC HORMONE WITH ORAL INDOMETHACIN IN THE TREATMENT OF ACUTE GOUT [J].
AXELROD, D ;
PRESTON, S .
ARTHRITIS AND RHEUMATISM, 1988, 31 (06) :803-805
[8]
Serum uric acid and cardiovascular disease: Recent developments, and where do they leave us? [J].
Baker, JF ;
Krishnan, E ;
Chen, L ;
Schumacher, HR .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (08) :816-826
[9]
Serum uric acid level and risk for peripheral arterial disease: Analysis of data from the multiple risk factor intervention trial [J].
Baker, Joshua F. ;
Schumacher, H. Ralph ;
Krishnan, Eswar .
ANGIOLOGY, 2007, 58 (04) :450-457
[10]
Current management of gout in patients unresponsive or allergic to allopurinol [J].
Bardin, T .
JOINT BONE SPINE, 2004, 71 (06) :481-485